Company poster presentations will debut research data of three lead drug candidates constructed with Company’s novel TRBC platform technology…
MIRAMAR, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) — HCW Biologics Inc. (“HCWB” or the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies to extend healthspan … [5510 chars]
Source: GlobeNewswire | Published: 2025-10-16T00:00:00Z
Credit: GlobeNewswire
